Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up.
J Vasc Interv Radiol
; 18(11): 1451-3, 2007 Nov.
Article
em En
| MEDLINE
| ID: mdl-18003999
ABSTRACT
Orthotopic liver transplantation is frequently performed for patients with end-stage liver disease complicated by the development of small hepatocellular carcinomas (HCCs). Since the adaptation of the Milan criteria, the rate of posttransplantation recurrence has significantly decreased to a rate of 10%-20%. In the setting of recurrence after transplantation, survival rates are poor, with a median of 9 months. Survival can be extended with use of definitive therapies, most often surgical. The present report describes a patient with recurrent intrahepatic HCC after liver transplantation who was treated with radiofrequency ablation and has survived 24 months with normalization of alpha-fetoprotein levels and no evidence of viable tumor on imaging.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transplante de Fígado
/
Ablação por Cateter
/
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
/
Recidiva Local de Neoplasia
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article